INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE

The interaction of de novo and pre-existing aortic regurgitation after TAVI: insights from a new quantitative aortographic technique

EuroIntervention 2017;13:60-68 published online December 2016. DOI: 10.4244/EIJ-D-16-00647

Hiroki Tateishi
Hiroki Tateishi1, MD, PhD; Mohammad Abdelghani2, MD, MSc; Rafael Cavalcante1, MD, PhD; Yosuke Miyazaki1, MD, PhD; Carlos M. Campos3,4, MD, PhD; Carlos Collet2, MD; Tristan L.B. Slots5, BSc; Rogério S. Leite6, MD, PhD; José A. Mangione7, MD, PhD; Alexandre Abizaid3,8, MD, PhD; Osama I.I. Soliman1,9, MD, PhD; Ernest Spitzer1,9, MD; Yoshinobu Onuma1, MD, PhD; Patrick W. Serruys10*, MD, PhD; Pedro A. Lemos3, MD, PhD; Fabio S. de Brito Jr4, MD, PhD
1. Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands; 2. Academic Medical Center, Amsterdam, the Netherlands; 3. The Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil; 4. Hospital Israelita Albert Einstein,

Aims: The aim of this study was to evaluate the intermediate-term clinical impact of aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI) using a novel quantitat

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

aortic regurgitationparavalvular leakagetranscatheter aortic valve implantation (tavi)
Interventions for valvular diseaseTAVI
Read next article
France: coronary and structural heart interventions from 2010 to 2015

Latest news